Research progress on the use of targeted nanomedicine for the treatment of acute kidney injury

doi:10.3877/cma.j.issn.2095-3216.2025.03.001

Abstract

Abstract:

Currently， the treatment for acute kidney injury （AKI） primarily relies on supportive therapy， which yields suboptimal outcomes.Efficient nano-drug delivery system can specifically reach the kidneys and release drugs with precision，providing a new direction for specific treatment of AKI.This article reviewed the research progress of targeted nanomedicine therapy for AKI， with a focus on exploring strategies to improve the renal targeting efficiency of nanomedicine.

Key words: Acute kidney injury, Nanomedicine, Targeted therapy

Wanbing Qin, Qinghua Liu. Research progress on the use of targeted nanomedicine for the treatment of acute kidney injury[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2025, 14(03): 121-125.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2025.03.001

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2025/V14/I03/121

Figures/Tables 1

References 26

［1］	Al-Jaghbeer M， Dealmeida D， Bilderback A， et al.Clinical decision support for in-hospital AKI ［J］.J Am Soc Nephrol，2018，29（2）：654-660.
［2］	Yan J， Wang Y， Zhang J， et al.Rapidly blocking the calcium overload/ROS production feedback loop to alleviate acute kidney injury via microenvironment-responsive BAPTA-AM/BAC codelivery nanosystem ［J］.Small，2023，19（17）： e2206936.
［3］	Perazella M， Rosner M.Drug-induced acute kidney injury ［J］.Clin J Am Soc Nephrol，2022，17（8）：1220-1233.
［4］	Tanase D， Gosav E， Radu S， et al.The predictive role of the biomarker kidney molecule-1 （KIM-1） in acute kidney injury（AKI） cisplatin-induced nephrotoxicity ［J］.Int J Mol Sci，2019，20（20）：5238.
［5］	Alem C， Mark B， Jurrien P， et al.Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat ［J］.Nephrology， 2018，33（1）：44-53.
［6］	Tong F， Liu J， Luo L， et al.pH/ROS-responsive propelled nanomotors for the active treatment of renal injury ［ J］.Nanoscale，2023，15（14）：6745-6758.
［7］	He X， Alves C， Oliveira N， et al.RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells ［ J］.Colloids Surf B Biointerfaces，2015，125：82-89.
［8］	Awad R， Avital A， Sosnik A.Polymeric nanocarriers for noseto-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders ［J］.Acta Pharm Sin B，2023，13（5）：1866-1886.
［9］	Kong L， Fan D， Zhou L， et al.The influence of modified molecular （ D/L-serine） chirality on the theragnostics of PAMAM-based nanomedicine for acute kidney injury ［J］.J Mater Chem B，2021，9（43）：9023-9030.
［10］	Yu S， Xu X， Feng J， et al.Chitosan and chitosan coating nanoparticles for the treatment of brain disease［J］.Int J Pharm，2019，560：282-293.
［11］	Wang D， Li S， Tan X， et al.Engineering of stepwise-targeting chitosan oligosaccharide conjugate for the treatment of acute kidney injury ［J］.Carbohydr Polym，2021，256：117556.
［12］	Jiang D， Ge Z， Im H， et al.DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury［J］.Nat Biomed Eng，2018，2（11）：865-877.
［13］	Zhang D， Qi B， Li D， et al.Phillyrin relieves lipopolysaccharide-induced AKI by protecting against glycocalyx damage and inhibiting inflammatory responses ［ J ］.Inflammation，2020，43（2）：540-551.
［14］	Chen Y， Lin L， Tao X， et al.The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and postinjury fibrosis ［J］.BMC Nephrol，2019，20（1）：106.
［15］	Huang Y，Wang J，Jiang K，et al.Improving kidney targeting： the influence of nanoparticle physicochemical properties on kidney interactions ［J］.J Control Release，2021，334：127-137.
［16］	Williams R， Shah J， Ng B， et al.Mesoscale nanoparticles selectively target the renal proximal tubule epithelium ［J］.Nano Lett，2015，15（4）：2358-2364.
［17］	Huang J， Guo J， Dong Y， et al.Self-assembled hyaluronic acidcoated nanocomplexes for targeted delivery of curcumin alleviate acute kidney injury ［J］.Int J Biol Macromol，2023，226：1192-1202.
［18］	Li J， Duan Q， Wei X， et al.Kidney-targeted nanoparticles loaded with the natural antioxidant rosmarinic acid for acute kidney injury treatment ［J］.Small，2022，18（48）： e2204388.
［19］	Liu D， Jin F， Shu G， et al.Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes ［J］.Biomaterials，2019，211：57-67.
［20］	Yu H， Jin F， Liu D， et al.ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury ［J］.Theranostics，2020，10（5）：2342-2357.
［21］	Holditch SJ， Brown CN， Lombardi AM， et al.Recent advances in models， mechanisms， biomarkers， and interventions in cisplatin-induced acute kidney injury ［J］.Int J Mol Sci，2019，20（12）：3011.
［22］	Fan X， Zhang X， Liu L， et al.Hemopexin accumulates in kidneys and worsens acute kidney injury by causing hemoglobin deposition and exacerbation of iron toxicity in proximal tubules［J］.Kidney Int，2022，102（6）：1320-1330.
［23］	Deng L， Xiao M， Wu A， et al.Se/albumin nanoparticles for inhibition of ferroptosis in tubular epithelial cells during acute kidney injury ［J］.ACS Appl Nano Mater，2022，5（1）：227-236.
［24］	Duan R， Li Y， Zhang R， et al.Reversing acute kidney injury through coordinated interplay of anti-inflammation and iron supplementation ［ J］.Adv Mater， 2023， 35 （ 28 ）：e2301283.
［25］	Yang Y， Liu Y， Wang Y， et al.Regulation of SIRT1 and its roles in inflammation ［J］.Front Immunol，2022，13：831168.
［26］	Li X， Wang Q， Deng G， et al.Porous Se@ SiO2 nanospheres attenuate cisplatin-induced acute kidney injury via activation of Sirt1 ［J］.Toxicol Appl Pharmacol，2019，380：114704.

[1]	Jinze Li, Yaqi Peng, Yueping Liu, Li Ma. Clinical insights on HER-2-low and HER-2-ultralow in breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2025, 19(02): 70-75.
[2]	Limin Wang, Xiaojian Zhou. Expression of lncRNA and related miRNA in hypoxic-ischemic brain damage [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2025, 21(02): 145-150.
[3]	Peizhen Li, Hailiang Liu, Dawei Li, Hao Jia, Zejin Zhang, Liwei Liu, Shen Chuan'an Shen. Analysis of risk factors for early acute kidney injury in patients with severe burns and establishment of a prediction model [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2025, 20(03): 199-205.
[4]	Chuying Wu, Kai Ye. Laparoscopic surgical strategies for different sites of gastrointestinal stromal tumors [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(02): 224-227.
[5]	Botao Chen, Kuan Hu, Xianhai Mao. Tumor microenvironment and systematic treatment of gallbladder cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(02): 203-208.
[6]	Chunlin Wu, Yifu Hou, Kai Chen, Ji Zhao, Shijie Tang, Hongji Yang. Safety and efficacy of hepatic arterial infusion chemotherapy combined with PD-1/TKI for unresectable hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(02): 217-224.
[7]	Chunjia Sheng, Yuhao Chen, Fei Peng, Jikai Xia, Xiaofan Li, Jianwen Chen, Chuyue Zhang, Lingling Wu, Jiaona Liu, Xueyuan Bai, Xiangmei Chen. Epigallocatechin gallate improved acute kidney injury in mice by inhibiting cellular senescence [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2025, 14(03): 133-139.
[8]	Sha Luo, Lele Qiu, Xiang Yu, Zhe Feng, Guangyan Cai, Jing Huang. Application research of new non-invasive volume assessment technology in continuous renal replacement therapy for patients with acute kidney injury [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2025, 14(02): 61-67.
[9]	Fei Li, Xiaoxia Guo, Yue Zheng, Xi Zheng, Xincheng Li, Wenxiong Li. Impact of statins on the prognosis of sepsis-associated acute kidney injury patients with elevated triglyceride-glucose index [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2025, 14(02): 68-76.
[10]	Jiaxin Zhang, Yang Liu, Zhen Wu, Qingli Cheng, Qiangguo Ao. Impact of hypernatremia on short-term prognosis of elderly patients with in-hospital acute kidney injury [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2025, 14(02): 83-90.
[11]	Keying Zhang, Yuwei Ji, Zhangning Fu, Yifan Zhang, Xiaochen Wang, Yan Yang, Xiangmei Chen, Guangyan Cai, Quan Hong. Transcriptome analysis of mesenchymal stem cells pretreated with ginsenoside Rb1 and mining of key genes for treating acute kidney injury [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2025, 14(01): 26-33.
[12]	Ran Song, Yage Zheng. Evaluation of curative effect and analysis of factors influencing survival rate of unresectable advanced liver cancer treated with lenvatinib combined with TACE [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2025, 15(02): 120-124.
[13]	Chenchen Song, Tianci Liang, Yue Zhao, Chaoyi Zhang, Hui Wang, Tingzhi Wen, Biaoxue Rong. Advances in research of collagen type X alpha 1 in malignant tumors [J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(03): 221-228.
[14]	Jian Chen, Kaijian Xia, Lu Xu, Fuli Gao, Xiaodan Xu, Ganhong Wang. Development of a risk assessment model for acute kidney injury in cirrhotic patients based on automated machine learning [J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(02): 129-139.
[15]	Yuqi Liu, Jian Li, Jie Zhong, Qun Li, Shuai Chang, Chunpeng Yu. Clinical efficacy and safety analysis of microwave ablation synchronized with hepatic artery chemoembolization combined with targeted and immune therapy for large hepatocellular carcinoma [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2025, 13(02): 110-116.

Please choose a citation manager

Content to export